Imaging Characteristics of CNS Neuroblastoma-FOXR2: A Retrospective and Multi-Institutional Description of 25 Cases

References

1. 1.↵
   1. Louis DN,
   2. Perry A,
   3. Wesseling P, et al

   . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 2021;23:1231–51 doi:10.1093/neuonc/noab106 pmid:34185076

   CrossRefPubMed
2. 2.↵
   1. Louis DN,
   2. Ohgaki H,
   3. Wiestler OD, et al

   . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97–109 doi:10.1007/s00401-007-0243-4 pmid:17618441

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Sturm D,
   2. Orr BA,
   3. Toprak UH, et al

   . New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 2016;164:1060–72 doi:10.1016/j.cell.2016.01.015 pmid:26919435

   CrossRefPubMed
4. 4.↵
   1. von Hoff K,
   2. Haberler C,
   3. Schmitt-Hoffner F, et al

   . Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study. Neuro Oncol 2021;23:1597–611 doi:10.1093/neuonc/noab136 pmid:34077956

   CrossRefPubMed
5. 5.↵
   1. Korshunov A,
   2. Okonechnikov K,
   3. Schmitt-Hoffner F, et al

   . Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation. Acta Neuropathol Commun 2021;9:20 doi:10.1186/s40478-021-01118-5 pmid:33536079

   CrossRefPubMed
6. 6.↵
   1. Holsten T,
   2. Lubieniecki F,
   3. Spohn M, et al

   . Detailed clinical and histopathological description of 8 cases of molecularly defined CNS neuroblastomas. J Neuropathol Exp Neurol 2021;80:52–59 doi:10.1093/jnen/nlaa128 pmid:33270865

   CrossRefPubMed
7. 7.↵
   1. Furuta T,
   2. Moritsubo M,
   3. Muta H, et al

   . Central nervous system neuroblastic tumor with FOXR2 activation presenting both neuronal and glial differentiation: a case report. Brain Tumor Pathol 2020;37:100–104 doi:10.1007/s10014-020-00370-2 pmid:32535663

   CrossRefPubMed
8. 8.↵
   1. Capper D,
   2. Jones DTW,
   3. Sill M, et al

   . DNA methylation-based classification of central nervous system tumours. Nature 2018;555:469–74 doi:10.1038/nature26000 pmid:29539639

   CrossRefPubMed
9. 9.↵
   1. Stock A,
   2. Mynarek M,
   3. Pietsch T, et al

   . Characteristics of wingless pathway subgroup medulloblastomas: results from the German Imaging HIT/SIOP-Trial Cohort. AJNR Am J Neuroradiol 2019;40:1811–17 doi:10.3174/ajnr.A6286 pmid:31649159

   Abstract/FREE Full Text
10. 10.↵
    1. Ferris SP,
    2. Velazquez Vega J,
    3. Aboian M, et al

    . High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication: a comprehensive clinical, radiographic, pathologic, and genomic analysis. Brain Pathol 2020;30:46–62 doi:10.1111/bpa.12747 pmid:31104347

    CrossRefPubMed
11. 11.↵
    1. De Lima L,
    2. Sürme MB,
    3. Gessi M, et al

    . Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR): case-based reviews. Childs Nerv Syst 2020;36:1589–99 doi:10.1007/s00381-020-04692-6 pmid:32542405

    CrossRefPubMed
12. 12.
    1. Hu W,
    2. Wang J,
    3. Yuan L, et al

    . Case report: a unique case of pediatric central nervous system embryonal tumor harboring the CIC–LEUTX fusion, germline NBN variant and somatic TSC2 mutation: expanding the spectrum of CIC-rearranged neoplasia. Front Oncol 2020;10:598970 doi:10.3389/fonc.2020.598970 pmid:33344249

    CrossRefPubMed
13. 13.↵
    1. Cardoen L,
    2. Tauziède-Espariat A,
    3. Dangouloff-Ros V, et al

    . Imaging features with histopathologic correlation of CNS high-grade neuroepithelial tumors with a BCOR internal tandem duplication. AJNR Am J Neuroradiol 2022;43:151–56 doi:10.3174/ajnr.A7367 pmid:34887247

    Abstract/FREE Full Text
14. 14.↵
    1. Jin B,
    2. Feng XY

    . MRI features of atypical teratoid/rhabdoid tumors in children. Pediatr Radiology 2013;43:1001–08 doi:10.1007/s00247-013-2646-9 pmid:23467756

    CrossRefPubMed
15. 15.
    1. Meyers SP,
    2. Khademian ZP,
    3. Biegel JA, et al

    . Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes. AJNR Am J Neuroradiol 2006;27:962–71 pmid:16687525

    PubMedWeb of Science
16. 16.
    1. Yamasaki K,
    2. Kiyotani C,
    3. Terashima K, et al

    . Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid/rhabdoid tumors: a retrospective study by the Japan Children’s Cancer Group. J Neurosurg Pediatr 2019;15:1–10 doi:10.3171/2019.9.PEDS19367 pmid:31731266

    CrossRefPubMed
17. 17.
    1. Mangalore S,
    2. Aryan S,
    3. Prasad C, et al

    . Imaging characteristics of supratentorial ependymomas: study on a large single institutional cohort with histopathological correlation. Asian J Neurosurg 2015;10:276–81 doi:10.4103/1793-5482.162702 pmid:26425155

    CrossRefPubMed
18. 18.
    1. Wang Q,
    2. Cheng J,
    3. Li J, et al

    . The survival and prognostic factors of supratentorial cortical ependymomas: a retrospective cohort study and literature-based analysis. Front Oncol 2020;10:1585 doi:10.3389/fonc.2020.01585 pmid:32974195

    CrossRefPubMed
19. 19.↵
    1. Warmuth-Metz M,
    2. Bison B,
    3. Gerber NU, et al

    . Bone involvement in atypical teratoid/rhabdoid tumors of the CNS. AJNR Am J Neuroradiol 2013;34:2039–42 doi:10.3174/ajnr.A3554 pmid:23681355

    Abstract/FREE Full Text
20. 20.↵
    WHO Classification of Tumours Editorial Board. Central Nervous System Tumours: Who Classification of Tumours. 5th ed. International Agency for Research on Cancer; December 2021
21. 21.↵
    1. Frühwald MC,
    2. Hasselblatt M,
    3. Nemes K, et al

    . Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors. Neuro Oncol 2020;22:1006–17 doi:10.1093/neuonc/noz244 pmid:31883020

    CrossRefPubMed
22. 22.↵
    1. Khan S,
    2. Solano-Paez P,
    3. Suwal T, et al

    . Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study. Lancet Child Adolesc Health 2021;5:800–13 doi:10.1016/S2352-4642(21)00245-5 pmid:34599879

    CrossRefPubMed
23. 23.↵
    1. Pajtler KW,
    2. Witt H,
    3. Sill M, et al

    . Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 2015;27:728–43 doi:10.1016/j.ccell.2015.04.002 pmid:25965575

    CrossRefPubMed
24. 24.↵
    1. Andreiuolo F,
    2. Varlet P,
    3. Tauziède-Espariat A, et al

    . Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features. Brain Pathol 2019;29:205–16 doi:10.1111/bpa.12659 pmid:30246434

    CrossRefPubMed
25. 25.↵
    1. Maier SE,
    2. Sun Y,
    3. Mulkern RV

    . Diffusion imaging of brain tumors. NMR Biomed 2010;23:849–64 doi:10.1002/nbm.1544 pmid:20886568

    CrossRefPubMedWeb of Science
26. 26.↵
    VASARI Research Project. March 30, 2020. https://wiki.cancerimagingarchive.net/display/Public/VASARI+Research+Project. Accessed May 29, 2022